Jane Street’s Maravai LifeSciences MRVI Stock Holding History

Jane Street’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$185K	Buy	65,400 +38,300	+141%	+$130K	﹤0.01%	10223
2025 Q4	$88.1K	Sell	27,100 -1,700	-6%	-$5.72K	﹤0.01%	10244
2025 Q3	$82.7K	Hold	28,800	–	–	﹤0.01%	10212
2025 Q2	$69.4K	Buy	+28,800	New	+$60.5K	﹤0.01%	9092
2024 Q2	–	Sell	-13,900	Closed	-$121K	–	9900
2024 Q1	$121K	Buy	+13,900	New	+$94K	﹤0.01%	8456
2022 Q4	–	Sell	-23,200	Closed	-$592K	–	9759
2022 Q3	$592K	Buy	+23,200	New	+$582K	﹤0.01%	6374
2022 Q2	–	Sell	-12,600	Closed	-$444K	–	10433
2022 Q1	$444K	Sell	12,600 -20,700	-62%	-$694K	﹤0.01%	7704
2021 Q4	$1.4M	Sell	33,300 -5,000	-13%	-$203K	﹤0.01%	5239
2021 Q3	$1.88M	Buy	38,300 +24,900	+186%	+$1.21M	﹤0.01%	4600
2021 Q2	$559K	Buy	+13,400	New	+$519K	﹤0.01%	7030

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's MRVI Position: Q1 2026 in Review

Jane Street increased its Maravai LifeSciences (MRVI) stake by 26% in Q1 2026, buying an estimated $1.16M and bringing the position to 1,636,145 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3638.

Jane Street first reported a position in MRVI in Q4 2020 and has held it in 20 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Jane Street held 1,636,145 shares of Maravai LifeSciences worth $4.63M as of Q1 2026.
Jane Street bought 341,087 Maravai LifeSciences shares in Q1 2026, an estimated $1.16M.
Maravai LifeSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3638 holding.
Jane Street first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 20 quarters since.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.